Vaxcyte, Inc.(PCVX)
Biotechnology
Infectious Disease Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -2,250 | -1.40%158,494 | $49.52 | $111,416 | View SEC filing | |
| 2026-05-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -2,250 | -1.38%160,744 | $56.83 | $127,870 | View SEC filing | |
| 2026-04-08 | Cowan Elvia SVP, Finance & CAO | Sale | -3,000 | -9.38%28,975 | $60.00 | $180,000 | View SEC filing | |
| 2026-04-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -2,250 | -2.29%162,994 | $58.43 | $131,476 | View SEC filing | |
| 2026-03-18 | Cowan Elvia SVP, Finance & CAO | Sale | -1,892 | -6.13%28,975 | $55.57 | $105,147 | View SEC filing | |
| 2026-03-11 | Cowan Elvia SVP, Finance & CAO | Sale | -2,500 | -7.49%30,867 | $58.59 | $146,482 | View SEC filing | |
| 2026-03-11 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -7,395 | -4.24%166,818 | $58.88 | $435,440 | View SEC filing | |
| 2026-01-02 | Dhaliwal Harpreet S. Chief Technical Ops Officer | Sale | -9,743 | -28.94%23,928 | $46.69 | $454,891 | View SEC filing | |
| 2025-12-29 | Cowan Elvia SVP, FINANCE | Sale | -11,623 | -44.44%14,534 | $47.92 | $556,972 | View SEC filing | |
| 2025-03-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale | -5,000 | -10.73%41,620 | $70.74 | $353,699 | View SEC filing | |
| 2025-03-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -8,000 | -4.91%154,931 | $73.27 | $586,165 | View SEC filing | |
| 2025-02-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale | -8,000 | -6.81%109,491 | $83.85 | $670,823 | View SEC filing | |
| 2025-02-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale | -5,000 | -15.05%28,222 | $90.07 | $450,369 | View SEC filing | |
| 2025-02-04 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -8,000 | -3.74%205,695 | $86.22 | $689,790 | View SEC filing | |
| 2025-01-22 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale | -8,000 | -6.81%109,491 | $86.51 | $692,101 | View SEC filing | |
| 2025-01-17 | Loxam Teri Director | Sale | -6,250 | -46.55%7,175 | $85.11 | $531,963 | View SEC filing | |
| 2025-01-07 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale | -5,000 | -15.05%28,222 | $85.58 | $427,923 | View SEC filing | |
| 2025-01-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -8,000 | -3.74%205,695 | $83.66 | $669,267 | View SEC filing | |
| 2024-12-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale | -8,000 | -6.81%109,491 | $88.78 | $710,249 | View SEC filing | |
| 2024-12-10 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale | -2,366 | -0.86%136,215 | $92.25 | $218,253 | View SEC filing | |
| 2024-12-09 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale | -5,000 | -14.84%28,697 | $91.49 | $457,434 | View SEC filing | |
| 2024-12-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale | -15,000 | -3.22%450,301 | $92.45 | $1,386,794 | View SEC filing | |
| 2024-12-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale | -8,000 | -3.74%205,695 | $92.49 | $739,885 | View SEC filing | |
| 2024-11-19 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale | -8,000 | -6.81%109,491 | $85.81 | $686,518 | View SEC filing | |
| 2024-11-08 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale | -2,366 | -0.85%137,398 | $103.89 | $245,796 | View SEC filing |
1-25 of 206